LAST PRICE - AT THE CLOSE
CURE is UP 12% since the begininning of the year
CURE is UP 6% ABOVE 20 day SMA
CURE is UP 20% ABOVE 200 day SMA
PROFITABLE: N/A
EPS: N/A
EARNINGS MOMENTUM: N/A
N/A INCREASE IN QTRLY EARNINGS
P/E RATIO IS: N/A
INCOME TO DEBT RATIO: N/A
 |
THE STOCK IS 16.3% AWAY FROM ALL-TIME HIGHS OF $149.575 |
 |
CURE IS UP 12% SINCE THE BEGINNING OF THE YEAR |
 |
CURE IS UP 85% OVER THE PAST 12 MONTHS |
 |
CURE IS UP 5% OVER THE PAST 1 MONTH |
 |
N/A% OF ALL CURE INVESTORS ARE BETTING AGAINST CURE |
 |
NUM INVESTORS SHORT CURE HAS GONE UP N/A% VERSUS LAST MONTH |
| Type | Description | Time |
|---|---|---|
 | New premarket high. ... | 08/07 |
 | New premarket low. ... | 08/07 |
 | Trading 2% above exp... | 08/07 |
 | Trading 1% above VWA... | 08/07 |
 | Trading 1% below VWA... | 08/07 |
 |
CURE moved up 0 in the previous minute |
 |
CURE is up 0 over the last hour |
 |
CURE is up 3.8% over the last 5 days |
 |
CURE is 2.8 above its 8 day SMA |
| $118.81 |   DAY |
$125.18 |
| $119.41 | PREVIOUS DAY |
$128.00 |
| $114.82 | WEEK |
$128.00 |
| $107.59 | MONTH |
$132.00 |
| $66.00 | YEAR |
$132.00 |
CURE is mentioned N/A less than normal on 
CURE is mentioned N/A times in an average day on 
